Search Results - "Wang, Xiaofei F" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

by SCHROEN, Anneke T, PETRONI, Gina R, DJULBEGOVIC, Benjamin, SLINGLUFF, Craig L, HONGKUN WANG, THIELEN, Monika J, GRAY, Robert, BENEDETTI, Jacqueline, WANG, Xiaofei F, SARGENT, Daniel J, WICKERHAM, Donald L, CRONIN, Walter
Published in Clinical cancer research (01.01.2012)

Get full text

Journal Article

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

by Foster, Nathan R., Renfro, Lindsay A., Schild, Steven E., Redman, Mary W., Wang, Xiaofei F., Dahlberg, Suzanne E., Ding, Keyue, Bradbury, Penelope A., Ramalingam, Suresh S., Gandara, David R., Shibata, Taro, Saijo, Nagahiro, Vokes, Everett E., Adjei, Alex A., Mandrekar, Sumithra J.
Published in Journal of thoracic oncology (01.07.2015)

Get full text

Journal Article

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

by Clarke, Jeffrey M., Gu, Lin, Wang, Xiaofei F., Stinchcombe, Thomas E., Stevenson, Marvaretta M., Ramalingam, Sundhar, Shariff, Afreen, Garst, Jennifer, Nixon, Andrew B., Antonia, Scott J., Crawford, Jeffrey, Ready, Neal E.
Published in JTO clinical and research reports (01.06.2022)

Get full text

Journal Article

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non–small cell lung cancer: Results from Cancer and Leukemia Group B 159902

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non–small cell lung cancer: Results from Cancer and Leukemia Group B 159902

by Boylan, Alice M., MD, Wang, Xiaofei F., PhD, Ko, Richard, DO, Watson, Patricia M., PhD, Gu, Lin, MS, Harpole, David, MD, Bueno, Raphael, MD, Kelly, Rosemary, MD, Kohman, Leslie, MD, Kratzke, Robert, MD
Published in The Journal of thoracic and cardiovascular surgery (01.07.2013)

Get full text

Journal Article

Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer

Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer

by Yang, Chi-Fu Jeffrey, Chan, Derek Y, Shah, Shivani A, Yerokun, Babatunde A, Wang, Xiaofei F, D'Amico, Thomas A, Berry, Mark F, Harpole, Jr, David H
Published in Annals of surgery (01.12.2018)

Get more information

Journal Article

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

by Baggstrom, Maria Q., Socinski, Mark A., Wang, Xiaofei F., Gu, Lin, Stinchcombe, Thomas E., Edelman, Martin J., Baker, Sherman, Feliciano, Josephine, Novotny, Paul, Hahn, Olwen, Crawford, Jeffrey A., Vokes, Everett E.
Published in Journal of thoracic oncology (01.05.2017)

Get full text

Journal Article

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

by Schroen, Anneke T, Petroni, Gina R, Hongkun Wang, Gray, Robert, Wang, Xiaofei F, Cronin, Walter, Sargent, Daniel J, Benedetti, Jacqueline, Wickerham, Donald L, Djulbegovic, Benjamin, Slingluff, Craig L
Published in Clinical trials (London, England) (01.08.2010)

Get full text

Journal Article

Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial

Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial

by Liptay, Michael J., D'amico, Thomas A., Nwogu, Chumy, Demmy, Todd L., Wang, Xiaofei F., Gu, Lin, Litle, Virginia R., Swanson, Scott J., Kohman, Leslie J.
Published in Journal of thoracic oncology (01.02.2009)

Get full text

Journal Article

A Novel Rat Model with Obesity-Associated Retinal Degeneration

A Novel Rat Model with Obesity-Associated Retinal Degeneration

by Reddy, Geereddy Bhanuprakash, Vasireddy, Vidyullatha, Mandal, Md Nawajes A, Tiruvalluru, Mrudula, Wang, Xiaofei F, Jablonski, Monica M, Nappanveettil, Giridharan, Ayyagari, Radha
Published in Investigative ophthalmology & visual science (01.07.2009)

Get full text

Journal Article

Elovl4 5-bp-Deletion Knock-in Mice Develop Progressive Photoreceptor Degeneration

Elovl4 5-bp-Deletion Knock-in Mice Develop Progressive Photoreceptor Degeneration

by Vasireddy, Vidyullatha, Jablonski, Monica M, Mandal, Md Nawajes A, Raz-Prag, Dorit, Wang, Xiaofei F, Nizol, Lesli, Iannaccone, Alessandro, Musch, David C, Bush, Ronald A, Salem, Norman, Jr, Sieving, Paul A, Ayyagari, Radha
Published in Investigative ophthalmology & visual science (01.10.2006)

Get full text

Journal Article

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

by Schroen, Anneke T, Petroni, Gina R, Wang, Hongkun, Thielen, Monika J, Sargent, Daniel, Benedetti, Jacqueline K, Cronin, Walter M, Wickerham, Donald L, Wang, Xiaofei F, Gray, Robert, Cohn, Wendy F, Slingluff, Craig L, Djulbegovic, Benjamin
Published in Clinical trials (London, England) (01.10.2011)

Get full text

Journal Article

Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002

Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002

by Miller, Antonius A., Wang, Xiaofei F., Bogart, Jeffrey A., Hodgson, Lydia D., Lima, Caio M. S. Rocha, Radford, James E., Vokes, Everett E., Green, Mark R.
Published in Journal of thoracic oncology (01.07.2007)

Get full text

Journal Article

Phase II Randomized Study of Dose-Dense Docetaxel and Cisplatin Every 2 Weeks With Pegfilgrastim and Darbepoetin Alfa With and Without the Chemoprotector BNP7787 in Patients With Advanced Non-small Cell Lung Cancer (CALGB 30303)

Phase II Randomized Study of Dose-Dense Docetaxel and Cisplatin Every 2 Weeks With Pegfilgrastim and Darbepoetin Alfa With and Without the Chemoprotector BNP7787 in Patients With Advanced Non-small Cell Lung Cancer (CALGB 30303)

by Miller, Antonius A., Wang, Xiaofei F., Gu, Lin, Hoffman, Philip, Khatri, Jamil, Dunphy, Frank, Edelman, Martin J., Bolger, Michael, Vokes, Everett E., Green, Mark R.
Published in Journal of thoracic oncology (01.10.2008)

Get full text

Journal Article

Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes

Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes

by Vasireddy, Vidyullatha, Vijayasarathy, Camasamudram, Huang, Jibiao, Wang, Xiaofei F, Jablonski, Monica M, Petty, Howard R, Sieving, Paul A, Ayyagari, Radha
Published in Molecular vision (30.08.2005)

Get full text

Journal Article

Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer immunotherapy studies

Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer immunotherapy studies

by Pang, Herbert, Leung, Tiffany H, Ho, James C. M., Lam, Wendy WT, Wang, Xiaofei F.
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101)

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101)

by Mansfield, Aaron Scott, Wang, Xiaofei F., Wigle, Dennis A., Watt, Colleen, Masters, Gregory A., Kelley, Kathryn, Kozono, David E., Stinchcombe, Tom
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Preliminary results of single arm phase 2 trial of brigatinib in patients (pts) with progression disease (PD) after next-generation (NG) anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) in ALK + non-small cell lung cancer (NSCLC)

Preliminary results of single arm phase 2 trial of brigatinib in patients (pts) with progression disease (PD) after next-generation (NG) anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) in ALK + non-small cell lung cancer (NSCLC)

by Stinchcombe, Tom, Doebele, Robert Charles, Wang, Xiaofei F., Gerber, David E., Horn, Leora, Camidge, D. Ross
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC)

A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC)

by Saltos, Andreas Nicholas, Arrowood, Christy, Beasley, Georgia, Ronald, James, El-Haddad, Ghassan, Guerra-Guevara, Luiziane, Khan, Uzma, Wolf, Steven, Gu, Lin, Wang, Xiaofei F., Foresman, Dana, Yu, Xiaoqing, Cantwell, Mark J., Antonia, Scott Joseph, Beg, Amer A, Ready, Neal E.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

The importance of body composition and physical function on overall survival (OS) in non-small cell lung cancer (NSCLC) patients receiving platinum based chemotherapy (PBCT)

The importance of body composition and physical function on overall survival (OS) in non-small cell lung cancer (NSCLC) patients receiving platinum based chemotherapy (PBCT)

by Kinsey, Emily, Ajazi, Elizabeth, Wang, Xiaofei F., Johnston, Mary Ann, Crawford, Jeffrey
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Randomized phase 2 study of maintenance pemetrexed (Pem) versus observation (Obs) for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB) 30901 (Alliance)

Randomized phase 2 study of maintenance pemetrexed (Pem) versus observation (Obs) for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB) 30901 (Alliance)

by Dudek, Arkadiusz Z., Wang, Xiaofei F., Gu, Lin, Stinchcombe, Tom, Kratzke, Robert Arthur, Vokes, Everett E., Kindler, Hedy L.
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article